Browse through our

Recent Posts

Prostate Cancer Market experiences an Influx of the Pharma Players Veering the Market Ahead

Articles

The Prostate Cancer Market Size is Expected to Increase with a CAGR of 8.1% in the 7MM for the...

Read More

Gene-edited T cells for diabetes treatment; Pliant raised $144 million; Accent, AstraZeneca aim RNA modifiers in cancer deal; NodThera Raises $55M;

News

Gene-edited T cells for diabetes treatment The Scientists at the Seattle Children’s Research...

Read More

What are the 10 early signs of Alzheimer’s that are overlooked?

Articles

Alzheimer’s is a brain disease, associated with the degeneration of brain cells. It is an...

Read More

Eli Lilly’s COVID-19 Antibody trial; Approval for Oriahnn; Gilead’s Remdesivir Clinical Trials result; Russia approves Avifavir to treat Covid-19

Articles

Eli Lilly and AbCellera announced the dosing of the patients suffering from COVID-19 with antibody...

Read More

An Ageing Population and Upcoming Therapies: What is shaping the Alzheimer’s Disease Market Scenario?

Articles, Business Consultant, Pharma Consultant

The ageing population is a global phenomenon. According to the UN’s “World Population Prospects...

Read More

One of the leading causes of blindness, and a sight-threatening disease, Uveitis, now has novel treatment approaches in its pipeline

Articles

Uveitis is an ocular inflammation of the uveal tract, the middle layer of the eyeball. The uveal...

Read More
Have a glance at our

Featured Posts

Gene-edited T cells for diabetes treatment; Pliant raised $144 million; Accent, AstraZeneca aim RNA modifiers in cancer deal; NodThera Raises $55M;

News

Gene-edited T cells for diabetes treatment The Scientists at the Seattle Children’s Research Institute and the Benaroya Research Institute have got a promising finding that will turn off ...

Read More

What are the 10 early signs of Alzheimer’s that are overlooked?

Articles

Alzheimer’s is a brain disease, associated with the degeneration of brain cells. It is an ...

Read More

An Ageing Population and Upcoming Therapies: What is shaping the Alzheimer’s Disease Market Scenario?

Articles, Business Consultant, Pharma Consultant

The ageing population is a global phenomenon. According to the UN’s “World Population Prospects ...

Read More

One of the leading causes of blindness, and a sight-threatening disease, Uveitis, now has novel treatment approaches in its pipeline

Articles

Uveitis is an ocular inflammation of the uveal tract, the middle layer of the eyeball. The ...

Read More

Sign Up to access to our Newsletters.

Explore the untraversed paths through our deep insights into changing scenario of Pharma and
Biotech industry.

Our analytical perspectives on the issues that matter most in Pharma Space

Editor's pick

Eli Lilly’s COVID-19 Antibody trial; Approval for Oriahnn; Gilead’s Remdesivir Clinical Trials result; Russia approves Avifavir to treat Covid-19

Articles

Eli Lilly and AbCellera announced the dosing of the patients suffering from COVID-19 with antibody...

Read More

An Ageing Population and Upcoming Therapies: What is shaping the Alzheimer’s Disease Market Scenario?

Articles, Business Consultant, Pharma Consultant

The ageing population is a global phenomenon. According to the UN’s “World Population Prospects...

Read More

One of the leading causes of blindness, and a sight-threatening disease, Uveitis, now has novel treatment approaches in its pipeline

Articles

Uveitis is an ocular inflammation of the uveal tract, the middle layer of the eyeball. The uveal...

Read More

Startup focuses tumors with CAR-T; AbCellera grabs USD 105M; Gilead inks USD 2B deal; GSK’s anti-BCMA antibody receives a boost

News

The startup focuses on glioblastoma tumors with CAR-T therapy. CAR-T technology that involves...

Read More

Precision Medicine: An emerging approach to conventional treatment

Articles

As per WHO, “Cancer is the second leading cause of death globally and is responsible for an...

Read More

Discover new pharma market trends and stay up-to-date.

In order to strive in this ever-changing pharma market, innovation has become a vitally important aspect to grow in the industry.

(Visited 2,449 times, 1 visits today)
Close